Boston Scientific Stent, With New Drug Coating, Wins FDA Approval Xconomy The FDA cleared for sale the Promus stent that secretes everolimus, a drug designed to reduce scar tissue around the device and reduce blockages. Natick, MA-based Boston Scientific currently sells the Taxus stent coated with paclitaxel, so the approval ... |
